Search Results - "Samyshkin, Yevgeniy"

Characteristics and treatment patterns in patients with multiple myeloma in Japan: A retrospective cohort analysis.

Authors: Iida, Shinsuke Yasutomi, Yusuke Samyshkin, Yevgeniy et al.

Source: PLoS ONE. 1/23/2025, Vol. 20 Issue 1, p1-14. 14p.

SA25 Burden of Administration: Belantamab Mafodotin (Belamaf) Combinations vs Isatuximab (Isa) + Carfilzomib (K) + Dexamethasone (d), Daratumumab (D) + K + d, and K + d in Relapsed/Refractory Multiple Myeloma (RRMM).

Authors: SAMYSHKIN, Yevgeniy Purser, Molly Dlotko, Ewa et al.

Source: Value in Health. 2025 Supplement 1, Vol. 28 Issue 6, pS399-S399. 1p.

This result is not displayed to guests.
Login for full access.

An Epidemiology Model for Estimating the Numbers of US Patients With Multiple Myeloma by Line of Therapy and Treatment Exposure.

Authors: Nikolaou, Andreas Hogea, Cosmina Samyshkin, Yevgeniy et al.

Source: Value in Health. Dec2022, Vol. 25 Issue 12, p1977-1985. 9p.

Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer.

Authors: Lorusso, Domenica Guy, Holly Samyshkin, Yevgeniy et al.

Source: Cancers. Mar2022, Vol. 14 Issue 5, p1285. 1p.

EE282 Quality-Adjusted Life Year (QALY) Results From a Cost-Effectiveness Model for Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Relapsed/Refractory Multiple Myeloma (RRMM).

Authors: Kaiser, Martin Suvannasankha, Attaya Lee, Dawn et al.

Source: Value in Health. 2025 Supplement 1, Vol. 28 Issue 6, pS114-S115. 2p.

EE157 Cost-Effectiveness Analysis of Momelotinib for the Treatment of Adult Patients With Myelofibrosis and Anemia in Canada.

Authors: Riemer, Justin D. Groff, Michael Raad, Angie et al.

Source: Value in Health. 2025 Supplement 1, Vol. 28 Issue 6, pS90-S91. 2p.

Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery.

Alternate Title: Reforma de la atención de salud mental en la Federación de Rusia: enfoque integrado para propiciar la inserción social y la recuperación.
Réforme de la santé mentale dans la Fédération de Russie : démarche intégrée favorisant l'intégration sociale et le rétablissement des malades.

Authors: Jenkins, Rachel Lancashire, Stuart McDaid, David et al.

Source: Bulletin of the World Health Organization. Nov2007, Vol. 85 Issue 11, p858-866. 9p. 4 Charts.

EE327 Belantamab Mafodotin, Pomalidomide, and Dexamethasone (BPd) in Relapsed/Refractory Multiple Myeloma (RRMM): Quality-Adjusted Life-Year (QALY) Results From a Cost-Effectiveness Model.

Authors: Suvannasankha, Attaya Kaiser, Martin Lee, Dawn et al.

Source: Value in Health. 2025 Supplement 1, Vol. 28 Issue 6, pS122-S122. 1p.

External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.

Authors: Hoogendoorn, Martine Feenstra, Talitha L. Asukai, Yumi et al.

Source: Value in Health. Mar2017, Vol. 20 Issue 3, p397-403. 7p.

Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?

Authors: Hoogendoorn, Martine Feenstra, Talitha L. Asukai, Yumi et al.

Source: Value in Health. Sep/Oct2016, Vol. 19 Issue 6, p800-810. 11p.

Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios.

Authors: Hoogendoorn, Martine Feenstra, Talitha L. Asukai, Yumi et al.

Source: Value in Health. Jul2014, Vol. 17 Issue 5, p525-536. 12p.

Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysis.

Authors: Nikolaou A Ambavane A Shah A et al.

Source: Expert review of hematology [Expert Rev Hematol] 2021 Dec; Vol. 14 (12), pp. 1137-1145. Date of Electronic Publication: 2021 Sep 20.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE

Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States.

Authors: Shah A Tosh JC Ambavane A et al.

Source: ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2021 Sep 10; Vol. 13, pp. 789-800. Date of Electronic Publication: 2021 Sep 10 (Print Publication: 2021).

Publication Type: Journal Article

Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101560564 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6981 (Print) Linking ISSN: 11786981 NLM ISO Abbreviation: Clinicoecon Outcomes Res Subsets: PubMed not MEDLINE

Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom.

Authors: Samyshkin Y Kotchie RW Mörk AC et al.

Source: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2014 Jan; Vol. 15 (1), pp. 69-82. Date of Electronic Publication: 2013 Feb 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE

Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland.

Authors: Samyshkin Y Schlunegger M Haefliger S et al.

Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2013; Vol. 8, pp. 79-87. Date of Electronic Publication: 2013 Jan 30.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE

Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis.

Authors: Hertel N Kotchie RW Samyshkin Y et al.

Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2012; Vol. 7, pp. 183-99. Date of Electronic Publication: 2012 Mar 19.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE

Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension.

Authors: Kiely DG Doyle O Drage E et al.

Source: Pulmonary circulation [Pulm Circ] 2019 Nov 20; Vol. 9 (4), pp. 2045894019890549. Date of Electronic Publication: 2019 Nov 20 (Print Publication: 2019).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101557243 Publication Model: eCollection Cited Medium: Print ISSN: 2045-8932 (Print) Linking ISSN: 20458932 NLM ISO Abbreviation: Pulm Circ Subsets: PubMed not MEDLINE

High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project.

Authors: Bergemann R Allsopp J Jenner H et al.

Corporate Authors: Bergemann R Allsopp J Jenner H et al.

Source: Pulmonary circulation [Pulm Circ] 2018 Oct-Dec; Vol. 8 (4), pp. 2045894018798613.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101557243 Publication Model: Print Cited Medium: Print ISSN: 2045-8932 (Print) Linking ISSN: 20458932 NLM ISO Abbreviation: Pulm Circ Subsets: PubMed not MEDLINE

Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis.

Authors: Lee WC Samyshkin Y Langer J et al.

Source: Journal of medical economics [J Med Econ] 2012; Vol. 15 Suppl 2, pp. 28-37. Date of Electronic Publication: 2012 Aug 13.

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE